Technical Analysis for PHGUF - Pharming Grp Nv Leid

Grade Last Price % Change Price Change
grade B 1.26 0.00% 0.0000
PHGUF closed unchanged on Friday, August 16, 2019, on 14 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical PHGUF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Fell Below 200 DMA Bearish 3.28%
Wide Bands Range Expansion 3.28%
Overbought Stochastic Strength 3.28%

Older signals for PHGUF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Pharming Group NV (Pharming) is a Netherlands-based biotechnology company. The Company operates through two business segments, including Recombinant proteins, and DNage. Pharming focuses on the development, production and commercialization of human therapeutic proteins to be used as innovative therapies. The Company’s products are aimed at treatments for genetic disorders and surgical and traumatic bleeding. Pharming’s technologies include novel transgenic platforms for the production of biopharmaceuticals, as well as technology and processes for the purification and formulation of these biopharmaceuticals. The Company’s commercial partners are: Santarus, Sobi, MegaPharm, Eczacibasi, Transmedic and Hyupjin. The Company operates worldwide. In March 2014, it announced downsizing of the Dutch operations following from strategic re-emphasis on collaborative development efforts and out-sourcing of non-core activities.
Biotechnology Biopharmaceutical Life Sciences Biology Molecular Biology Biopharmaceuticals Biological Engineering Genetic Engineering Recombinant Dna Genetic Disorders Pharming
Is PHGUF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 1.96
52 Week Low 0.48
Average Volume 14,138
200-Day Moving Average 1.2897
50-Day Moving Average 0.9539
20-Day Moving Average 1.0123
10-Day Moving Average 1.166
Average True Range 0.0479
ADX 31.33
+DI 62.345
-DI 24.7946
Chandelier Exit (Long, 3 ATRs ) 1.1963
Chandelier Exit (Short, 3 ATRs ) 0.9287
Upper Bollinger Band 1.3642
Lower Bollinger Band 0.6604
Percent B (%b) 0.85
BandWidth 69.524844
MACD Line 0.1007
MACD Signal Line 0.0679
MACD Histogram 0.0328
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.2600
Resistance 3 (R3) 1.2600 1.2600 1.2600
Resistance 2 (R2) 1.2600 1.2600 1.2600 1.2600
Resistance 1 (R1) 1.2600 1.2600 1.2600 1.2600 1.2600
Pivot Point 1.2600 1.2600 1.2600 1.2600 1.2600
Support 1 (S1) 1.2600 1.2600 1.2600 1.2600 1.2600
Support 2 (S2) 1.2600 1.2600 1.2600 1.2600
Support 3 (S3) 1.2600 1.2600 1.2600
Support 4 (S4) 1.2600